Equities research analysts at StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Down 3.8 %
NASDAQ:AEZS opened at $3.80 on Friday. The company has a market capitalization of $6.81 million, a PE ratio of -0.26 and a beta of 1.55. Aeterna Zentaris has a 52-week low of $3.96 and a 52-week high of $12.00. The stock’s 50 day moving average price is $4.94 and its 200 day moving average price is $6.55.
About Aeterna Zentaris
Further Reading
- Five stocks we like better than Aeterna Zentaris
- What to Know About Investing in Penny Stocks
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Market Cap Calculator: How to Calculate Market Cap
- MarketBeat Week in Review – 9/23 – 9/27
- Using the MarketBeat Dividend Yield Calculator
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.